Status:
COMPLETED
GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes
Lead Sponsor:
Mikkel Christensen
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
MALE
18-70 years
Phase:
EARLY_PHASE1
Brief Summary
Investigation of GIP effects at fasting and hypoglycemia
Eligibility Criteria
Inclusion
- Caucasians 18 years or older with Type 2 diabetes (WHO criteria)
Exclusion
- HbA1c \>9 %
- Liver disease (ALAT/ASAT \>2 x upper normal limit)
- Diabetic nephropathy (s-creatinine \>130 µM or albuminuria)
- Proliferative diabetic retinopathy (anamnestic)
- Severe arteriosclerosis or heart failure (NYHA group III og IV)
- Anemia
- treatment with medication not applicable to pause for 12 hours
- Fasting plasma glucose \>15 mM on screening day.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01414556
Start Date
May 1 2011
End Date
November 1 2012
Last Update
April 2 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gentofte Hospital
Hellerup, Denmark, 2900